Effects of Noncardiovascular Comorbidities on Antihypertensive Use in Elderly Hypertensives
Why the study?
Does the presence of noncardiovascular comorbidities reduce antihypertensive use in elderly hypertensive patients?
Population
51,517 hypertensive patients ≥65 years of age in the Pennsylvania Pharmaceutical Assistance Contract for the…
Comparison
Presence of noncardiovascular comorbidities vs Absence of the 4 specified noncardiovascular…
Design
Cohort
Follow-up
1 year (1999 to 2000)
Authors
Discussion
Loading...
Member takes
Implication
May indicate undertreatment in comorbid elderly hypertensives; leaves open causal mechanisms and intervention targets.
Structured PICO
Does the presence of noncardiovascular comorbidities reduce antihypertensive use in elderly hypertensive patients?
P
Population
51,517 hypertensive patients ≥65 years of age in the Pennsylvania Pharmaceutical Assistance Contract for the Elderly (PACE) Program during 1999 and 2000
I
Intervention
Presence of noncardiovascular comorbidities (asthma/chronic obstructive pulmonary disease [COPD], depression, gastrointestinal [GI] disorders, or osteoarthritis)
C
Comparator
Absence of the 4 specified noncardiovascular comorbidities
O
Outcome
Proportion using antihypertensive medications in 2000
The presence of highly prevalent noncardiovascular comorbidities significantly deters the use of guideline-directed antihypertensive medications in elderly patients with hypertension.
Cite This Study
Wang et al. (2005) studied this question.